PRESS RELEASE published on 02/26/2024 at 14:00, 1 year 9 months ago FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM) FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRIEF published on 02/26/2024 at 14:00, 1 year 9 months ago FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™ FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
PRESS RELEASE published on 02/17/2024 at 01:10, 1 year 9 months ago FSD Pharma Announces US ATM Offering FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
PRESS RELEASE published on 02/06/2024 at 13:00, 1 year 9 months ago Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
PRESS RELEASE published on 01/29/2024 at 22:30, 1 year 10 months ago FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
PRESS RELEASE published on 01/16/2024 at 13:30, 1 year 10 months ago Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics. Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
PRESS RELEASE published on 12/23/2023 at 01:45, 1 year 11 months ago FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
PRESS RELEASE published on 12/05/2023 at 15:00, 1 year 11 months ago FSD Pharma Inc. Announces Closing of Private Placement FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
PRESS RELEASE published on 11/30/2023 at 14:30, 2 years ago FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities
PRESS RELEASE published on 11/28/2023 at 15:00, 2 years ago Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness
Published on 12/05/2025 at 02:35, 7 hours 10 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 45 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 40 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 45 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:30, 15 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 40 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 1 hour ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 45 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 1 minute ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health